DTx East: Day 2
Tuesday’s packed schedule will let attendees hear from Anders Tveteraas, international head of patient solutions and services at Novartis and Julie Anderson, principal, behavioural health s
Costco builds in telehealth with $29 online visit
US retailer Costco has made a play for a bigger slice of the healthcare market by offering its members online health visits, starting from just $29, as well as other servi
Ex-Novartis CMO John Tsai pops up at Forcefield
Novartis’ former chief medical officer John Tsai has returned to a senior position in biopharma, taking the role of chief executive of UK start-up Forcefield Therapeutics.
Ionis preps filings for olezarsen in rare disease FCS
Ionis Pharma is preparing to file for regulatory approval of its experimental therapy olezarsen for familial chylomicronaemia syndrome (FCS) in the US and Europe after the
NICE turns down Enhertu in “devastating” move, says charity
AstraZeneca and Daiichi Sankyo’s Enhertu should not be made available via the NHS for HER2-low metastatic or unresectable breast cancer after chemotherapy, according to pr
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Research2Guidance launches Allis.Health, a new digital healt...
(Berlin, Germany and Salerno, Italy) - On September 18th, 2023, Allis.Health, a new digital health analyst platform, offi
3rd mRNA-Based Therapeutics Summit Europe
250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content
Pharma & Patient USA 2023
Our ability to turn great products into great medicines has never been more reliant on how we engage with our patients, yet we’re still falling short of expectations and failing to build su
5th Inflammasome Therapeutics Summit returns to Boston!
The 5th Inflammasome Therapeutics Summit returns to Boston to unite industry pioneers at a critical time as clinical readouts are expected, and a wave of new collaborations hit the headline
